Restoration of Cementoblast Mineralization by Glutamine Under Inflammatory Conditions

Mengjie Yin, Hantao Yao, Jingqiu Chen, Ting Li, Yi-Lin Liao, Yaoyu Zhao, Yue Sheng, Wengwanyue Ye, Zhengguo Cao, Yaoting Ji, Hong HeInternational Dental Journal 2025 · DOI

TL;DR

Periodontitis, a common inflammatory disease, damages tooth-supporting tissues by impairing cementoblast function. This study reveals that Porphyromonas gingivalis infection disrupts cementoblast energy metabolism, leading to reduced mineralization. The researchers found that supplementing with glutamine can restore this mineralization by activating the AMPK/GLS pathway, offering a potential therapeutic strategy for periodontal regeneration.

What Problem Does This Paper Address?

Periodontitis and apical periodontitis are chronic inflammatory conditions that progressively destroy the cementum, periodontal ligament, and alveolar bone, often leading to tooth loss. Cementoblasts are crucial for forming and regenerating cementum, the tissue that anchors teeth. However, bacterial infections, like those caused by Porphyromonas gingivalis (P.g), a common culprit in periodontitis, are known to disrupt the metabolic environment of cementoblasts, hindering their ability to mineralize and regenerate. While the importance of energy metabolism in bone formation is established, the specific metabolic adaptations of cementoblasts under inflammatory stress and how they impact mineralization remained unclear. This paper aims to elucidate these metabolic changes and identify potential therapeutic targets to restore cementoblast function.

Methods

The researchers employed a multi-pronged approach:

  • In vitro cell models: They used the immortalized mouse cementoblast cell line OCCM-30 and infected it with P.g to mimic microbial infection. They also used TNF-α to simulate inflammation.
  • Metabolic profiling: Seahorse assays were used to measure cellular respiration (OCR) and glycolysis (PER), providing insights into energy production pathways. Untargeted metabolomics (LC-MS) was employed to identify changes in various metabolites.
  • Genetic manipulation: They used lentiviral vectors to create stable cell lines with reduced Glutaminase (GLS) expression (knockdown) and also overexpressed GLS to understand its role.
  • Pharmacological inhibition: The AMPK inhibitor Compound C was used to investigate the involvement of the AMPK pathway.
  • In vivo animal models: An apical periodontitis (AP) model was induced in C57BL/6 mice to evaluate the therapeutic effects of glutamine supplementation.
  • Molecular analysis: Techniques like qPCR and Western blotting were used to assess gene and protein expression levels of mineralization markers (Runx2, Sp7, Col1a1, Ocn, Alp, Bsp) and key metabolic enzymes (GLS, AMPK).
  • Histological and imaging analysis: ALP staining and activity assays were performed to assess mineralization capacity. Micro-CT and H&E staining were used for in vivo analysis of bone and cementum destruction.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from cell cultures and animal models.

Key Insights and Ideas

  • Inflammation hijacks energy production: P.g infection doesn't just cause inflammation; it actively suppresses the cementoblasts' primary energy production pathways (glycolysis and oxidative phosphorylation). This creates an "energy crisis" within the cells.
  • Glutamine as a metabolic lifeline: Instead of shutting down, cementoblasts adapt by upregulating glutamine metabolism. This suggests glutamine is a crucial alternative fuel source when other pathways are compromised.
  • The AMPK-GLS axis is key: The study identifies a critical signaling pathway where inflammatory stress activates AMPK, which in turn promotes the expression of GLS. GLS is the enzyme that initiates glutamine breakdown, making this axis central to the metabolic adaptation.
  • Targeting glutamine can restore function: By either supplementing with glutamine or overexpressing GLS, the researchers could partially restore the mineralization ability of cementoblasts, even under inflammatory conditions. This highlights the therapeutic potential of manipulating this pathway.
  • In vivo validation: The positive effects observed in cell cultures were mirrored in an animal model of apical periodontitis, where oral glutamine supplementation reduced bone and cementum destruction.

Key Results

  • P.g infection significantly reduced the expression of key mineralization markers (Runx2, Sp7, Col1a1) and ALP activity in cementoblasts.
  • Seahorse assays showed that P.g infection decreased both oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), indicating suppressed oxidative phosphorylation and glycolysis.
  • Metabolomic analysis revealed significant alterations in glutamine and glutamate metabolism, with upregulation of glutaminolysis enzymes.
  • Knockdown of GLS significantly inhibited cementoblast mineralization, while glutamine supplementation or GLS overexpression restored it.
  • AMPK activation was observed under inflammatory conditions, and inhibiting AMPK with Compound C reduced GLS expression and mineralization.
  • In mice with apical periodontitis, oral glutamine supplementation significantly reduced lesion area and preserved cementum area.

Limitations and Future Work

  • AMPK inhibitor limitations: The use of Compound C, an AMPK inhibitor, has potential off-target effects, which might limit the precision of the conclusions regarding the AMPK pathway. The authors suggest that future studies should utilize AMPK gene knockout or transgenic animal models for more definitive results.
  • Metabolic pathway complexity: While the study highlights glutamine metabolism, the precise role of α-KG in the TCA cycle and its contribution to energy metabolism under these conditions requires further investigation, potentially using isotopic tracing techniques.
  • Combinatorial therapies: The authors suggest that future research should explore combining metabolic modulation strategies with antimicrobial therapy to achieve more robust clinical outcomes in treating periodontitis.
  • Localized delivery: For in vivo applications, developing localized, sustained-release glutamine delivery systems could be a promising approach for promoting periodontal regeneration.

Summary updated

Abstract

Glutamine supplementation restores mineralization by the cementoblasts under inflammatory conditions, which provides a novel theoretical foundation for the alleviation and treatment of periodontitis and apical periodontitis.
BibTeX
@article{yin2025restoration,
  author = {Mengjie Yin and Hantao Yao and Jingqiu Chen and Ting Li and Yi-Lin Liao and Yaoyu Zhao and Yue Sheng and Wengwanyue Ye and Zhengguo Cao and Yaoting Ji and Hong He},
  title = {{Restoration of Cementoblast Mineralization by Glutamine Under Inflammatory Conditions}},
  journal = {International Dental Journal},
  year = {2025},
  doi = {10.1016/j.identj.2025.103930},
}
Figure